Recursion, Enamine generate 10 enriched libraries for drug discovery.

Recursion, a clinical stage TechBio company, has collaborated with Enamine to create 10 screening libraries from over 15,000 synthesized compounds. The libraries aim to accelerate drug discovery against 100 key targets in challenging biological areas using Enamine's REAL Space chemical library and Recursion's AI/ML platform. The collaboration aims to improve drug discovery and overcome the challenges of navigating the vast chemical space.

Ask Aime: What is the impact of Recursion's collaboration with Enamine on drug discovery and stock performance in the biotech sector?

View Source